Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Journal article

Emary KRW. et al, (2021), SSRN Electronic Journal

Is it time to consider IgG4-related disease in idiopathic retroperitoneal fibrosis?

Journal article

Teo L. et al, (2017), Journal of Clinical Urology, 10, 222 - 224